Budding, Kevin
Bos, Jeroen W.
Dijkxhoorn, Kim
de Zeeuw, Elisabeth
Bloemenkamp, Lauri M.
Zekveld, Eva M.
Groen, Ewout J.N.
Jacobs, Bart C.
Huizinga, Ruth
Goedee, H. Stephan
Cats, Elisabeth A.
Leusen, Jeanette H.W.
van den Berg, Leonard H.
Hack, C. Erik
van der Pol, W. Ludo
Article History
Received: 2 February 2024
Accepted: 2 April 2024
First Online: 17 April 2024
Declarations
:
: The Medical Ethical Committee of the University Medical Center Utrecht approved the collection of patient sera as part of a national cross-sectional study (UMCU, METC protocol nr: 14–528). Written informed consent was obtained from all study participants prior to inclusion in this study.
: Not applicable.
: KB, EdZ, KD, LMB are employees of the UMC Utrecht on a research service collaboration with argenx BVBA.JWB reports no disclosures.EMZ reports no disclosures.EJNG reports a research grants from the Prinses Beatrix Spierfonds and has received teaching fees from Biogen, all paid to the institution.BCJ reports grants for research from the GBS/CIDP Foundation International, Prinses Beatrix Spierfonds, Horizon 2020, NIH, Erasmus MC, Annexon, CSL-Behring, Grifols, Hansa Biopharma, Roche and Octapharma. BCJ is chairing the Steering Committee of the International GBS Outcome Study (IGOS), a member of the Advisory Board of Hansa Biopharma and Annexon and of the Global Medical Advisory Board of the GBS-CIDP Foundation International.RH reports grants from the GBS/CIDP Foundation International, NIH and the T2B collaboration project funded by PPP Allowance made available by Top Sector Life Sciences & Health to Samenwerkende Gezondheidsfondsen (SGF) under project number LSHM18055-SGF to stimulate public-private partnerships and co-financing by health foundations that are part of the SGF.HSG has received research grants from the Prinses Beatrix Spierfonds, speaker fees, and consultancy for Takeda and Quaralis all paid to the institution.EC reports no disclosures.JHWL reports no disclosures.LHvdB received an educational grant from Takeda; serves on the editorial boards of Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration; and receives research support from the Netherlands ALS Foundation.CEH provides consultancy services to argenx BVBA.WLvdP serves on the scientific advisory board for SAB SMA Europe; provides ad hoc consultancy for argenx BVBA, Biogen, and Novartis genetherapies; is the local PI for the ARDA and ARDA + trials and receives research support from the Prinses Beatrix Spierfonds, Vriendenloterij and Stichting Spieren voor Spieren.